Polydeoxyribonucleotide (PDRN), a tissue repair agent derived from purified salmon DNA, is gaining traction for scalp regeneration and hair growth support, according to clinical overviews and dermatological studies. While traditional hair loss treatments like minoxidil and finasteride target hormones or blood flow, PDRN functions by activating cellular repair pathways, prompting a closer look at its mechanisms, clinical data, and protocols.
What PDRN Is and How It Works on the Scalp
PDRN consists of specific chains of DNA fragments typically extracted and purified from salmon. According to dermatological reviews, it acts as a cellular stimulant rather than a classic growth factor or filler. When introduced to the scalp, PDRN targets adenosine A2A receptors, which triggers intracellular signals that boost collagen formation and cell growth, according to clinical literature. Additionally, the compound stimulates angiogenesis, forming new micro-blood vessels around hair follicles. This increased vascular supply delivers vital oxygen and nutrients to miniaturized follicles struggling in low-perfusion environments, while simultaneously mitigating chronic low-grade inflammation in surrounding tissue.
Clinical Data and Patient Outcomes
Clinical data supporting PDRN for hair loss remains early compared to long-standing therapeutics, but early trials demonstrate measurable results. A comparative clinical trial evaluating treatments for female pattern hair loss administered either platelet-rich plasma (PRP) or PDRN via scalp injections. While the PRP group yielded stronger overall hair count and thickness recovery, patients treated with PDRN still exhibited gains in hair density and shaft diameter over the study period. Because of these findings, PDRN is positioned as a viable alternative biologic for patients who cannot undergo PRP therapy or who require targeted support for scalp tissue quality.
Practical Protocols and Regenerative Combinations
Clinics rarely rely on a single modality, instead integrating PDRN into protocols that include exosomes, growth factor blends, and PRP.
Keep reading